Skip to content
healthcare.dev

Fruzaqla

NDC 63020-225, fruquintinib, capsule, from Takeda Pharmaceuticals America, Inc..

Product NDC
63020-225
Status
Listed
Labeler
Takeda Pharmaceuticals America, Inc.
Dosage form
CAPSULE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217564
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/63020-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FRUQUINTINIB5 mg/1
Package NDCNDC-11Package
63020-225-21630200225211 BOTTLE in 1 CARTON (63020-225-21) / 21 CAPSULE in 1 BOTTLE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/186d786e-dc8a-45f2-b5e1-01ac0201879f

Use it

Look up 63020-225 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/63020-225 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 63020-225. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.